A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer
一项I期研究评估了抗表皮生长因子受体(EGFR)抗体西妥昔单抗作为放射增敏剂联合放化疗治疗局部晚期胰腺癌的作用
期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-010-1383-0
Arnoletti, J P; Frolov, A; Eloubeidi, M; Keene, K; Posey, J; Wood, T; Greeno, Edward; Jhala, N; Varadarajulu, S; Russo, S; Christein, J; Oster, R; Buchsbaum, D J; Vickers, S M